Microbial Biotechnology: Dr. Helmy is interested in exploring the potential applications of microorganisms in biotechnological processes, such as the production of biofuels, bioremediation of environmental pollutants, and the synthesis of valuable biochemicals.

Nanobiotechnology: She investigates the intersection of nanotechnology and biotechnology, particularly the development of nanomaterials for use in medicine, agriculture, and food industries. This includes exploring nanomaterial-based drug delivery systems, biosensors, and antimicrobial agents.

Mycology and Fungal Systematics: With expertise in fungal systematics, Dr. Helmy studies the taxonomy, diversity, and ecological roles of fungi. She also investigates fungal secondary metabolites and their bioactivity for potential pharmaceutical and agricultural applications.

Probiotics and Gut Microbiota: Dr. Helmy is involved in research aimed at understanding the role of probiotic microorganisms in promoting human health, particularly through modulation of the gut microbiota. She explores the development of novel probiotic supplements and their effects on gastrointestinal disorders and immune function.

Bioanalytical Chemistry and Metabolomics: Her research interests extend to the chemical and pharmacological characterization of natural products from various sources, including fungi and plants. She utilizes bioanalytical techniques and metabolomics approaches to identify and analyze bioactive compounds with potential therapeutic applications.

Molecular Biology and Proteomics: Dr. Helmy is engaged in molecular biology research, focusing on DNA and RNA engineering, protein purification, and enzyme characterization. She employs techniques such as next-generation sequencing, PCR, RT-PCR, western blotting, and spectrophotometric analysis to investigate cellular and molecular processes.